<html xmlns:v="urn:schemas-microsoft-com:vml"xmlns:o="urn:schemas-microsoft-com:office:office"xmlns:w="urn:schemas-microsoft-com:office:word"xmlns="http://www.w3.org/TR/REC-html40"><head><meta name=Title content="OMLAB Editorial #070707"><meta name=Keywords content="INOS2008, ethical science"><meta http-equiv=Content-Type content="text/html; charset=macintosh"><meta name=ProgId content=Word.Document><meta name=Generator content="Microsoft Word 11"><meta name=Originator content="Microsoft Word 11"><link rel=File-List href="INOS_EthSci_files/filelist.xml"><title>OMLAB Editorial #070707</title><!--[if gte mso 9]><xml> <o:DocumentProperties>  <o:Subject>INOS 2008: Ethical Science</o:Subject>  <o:Author>L. F. Dell'Osso, Ph.D.</o:Author>  <o:Keywords>INOS2008, ethical science</o:Keywords>  <o:Template>Papers</o:Template>  <o:LastAuthor>OMLAB VAMC</o:LastAuthor>  <o:Revision>2</o:Revision>  <o:LastPrinted>2011-05-04T17:52:00Z</o:LastPrinted>  <o:Created>2011-05-04T17:52:00Z</o:Created>  <o:LastSaved>2011-05-04T17:52:00Z</o:LastSaved>  <o:Pages>6</o:Pages>  <o:Words>6517</o:Words>  <o:Characters>37149</o:Characters>  <o:Company>OMLAB</o:Company>  <o:Lines>309</o:Lines>  <o:Paragraphs>74</o:Paragraphs>  <o:CharactersWithSpaces>45621</o:CharactersWithSpaces>  <o:Version>11.1280</o:Version> </o:DocumentProperties> <o:OfficeDocumentSettings>  <o:AllowPNG/>  <o:PixelsPerInch>300</o:PixelsPerInch> </o:OfficeDocumentSettings></xml><![endif]--><!--[if gte mso 9]><xml> <w:WordDocument>  <w:Zoom>150</w:Zoom>  <w:ActiveWritingStyle Lang="EN-US" VendorID="8" DLLVersion="513" NLCheck="0">1</w:ActiveWritingStyle>  <w:DisplayHorizontalDrawingGridEvery>0</w:DisplayHorizontalDrawingGridEvery>  <w:DisplayVerticalDrawingGridEvery>0</w:DisplayVerticalDrawingGridEvery>  <w:UseMarginsForDrawingGridOrigin/>  <w:DocumentVariables>   <w:EN.InstantFormat>&lt;ENInstantFormat&gt;&lt;Enabled&gt;1&lt;/Enabled&gt;&lt;ScanUnformatted&gt;1&lt;/ScanUnformatted&gt;&lt;ScanChanges&gt;1&lt;/ScanChanges&gt;&lt;/ENInstantFormat&gt;</w:EN.InstantFormat>   <w:EN.Layout>&lt;ENLayout&gt;&lt;Style&gt;R_OMLAB&lt;/Style&gt;&lt;LeftDelim&gt;{&lt;/LeftDelim&gt;&lt;RightDelim&gt;}&lt;/RightDelim&gt;&lt;FontName&gt;Times&lt;/FontName&gt;&lt;FontSize&gt;12&lt;/FontSize&gt;&lt;ReflistTitle&gt;&lt;/ReflistTitle&gt;&lt;StartingRefnum&gt;1&lt;/StartingRefnum&gt;&lt;FirstLineIndent&gt;0&lt;/FirstLineIndent&gt;&lt;HangingIndent&gt;720&lt;/HangingIndent&gt;&lt;LineSpacing&gt;0&lt;/LineSpacing&gt;&lt;SpaceAfter&gt;0&lt;/SpaceAfter&gt;&lt;/ENLayout&gt;</w:EN.Layout>   <w:EN.Libraries>&lt;ENLibraries&gt;&lt;Libraries&gt;&lt;item&gt;EthSci.enl&lt;/item&gt;&lt;/Libraries&gt;&lt;/ENLibraries&gt;</w:EN.Libraries>   <w:EN_Lib_Name_List_Name>09OMref.enl</w:EN_Lib_Name_List_Name>  </w:DocumentVariables> </w:WordDocument></xml><![endif]--><style><!-- /* Font Definitions */@font-face	{font-family:"Times New Roman";	panose-1:0 2 2 6 3 5 4 5 2 3;	mso-font-charset:0;	mso-generic-font-family:auto;	mso-font-pitch:variable;	mso-font-signature:50331648 0 0 0 1 0;}@font-face	{font-family:Geneva;	panose-1:0 2 11 5 3 3 4 4 4 2;	mso-font-charset:0;	mso-generic-font-family:auto;	mso-font-pitch:variable;	mso-font-signature:50331648 0 0 0 1 0;} /* Style Definitions */p.MsoNormal, li.MsoNormal, div.MsoNormal	{mso-style-parent:"";	margin:0in;	margin-bottom:.0001pt;	mso-pagination:widow-orphan;	font-size:12.0pt;	font-family:Times;}h1	{mso-style-next:Normal;	margin:0in;	margin-bottom:.0001pt;	mso-pagination:widow-orphan;	page-break-after:avoid;	mso-outline-level:1;	font-size:14.0pt;	font-family:Times;	mso-font-kerning:0pt;	font-weight:normal;	font-style:italic;}h2	{mso-style-next:Normal;	margin:0in;	margin-bottom:.0001pt;	mso-pagination:widow-orphan;	page-break-after:avoid;	mso-outline-level:2;	font-size:12.0pt;	font-family:Times;	font-weight:normal;	font-style:italic;}h3	{mso-style-next:Normal;	margin:0in;	margin-bottom:.0001pt;	mso-pagination:widow-orphan;	page-break-after:avoid;	mso-outline-level:3;	font-size:14.0pt;	font-family:Times;	font-style:italic;}h4	{mso-style-next:Normal;	margin:0in;	margin-bottom:.0001pt;	text-align:center;	mso-pagination:widow-orphan;	page-break-after:avoid;	mso-outline-level:4;	font-size:12.0pt;	font-family:Times;}h5	{mso-style-next:Normal;	margin-top:0in;	margin-right:0in;	margin-bottom:0in;	margin-left:-27.0pt;	margin-bottom:.0001pt;	text-align:justify;	line-height:150%;	mso-pagination:widow-orphan;	page-break-after:avoid;	mso-outline-level:5;	font-size:14.0pt;	font-family:Times;	font-style:italic;}h6	{mso-style-next:Normal;	margin-top:0in;	margin-right:0in;	margin-bottom:0in;	margin-left:-27.0pt;	margin-bottom:.0001pt;	text-align:justify;	line-height:150%;	mso-pagination:widow-orphan;	page-break-after:avoid;	mso-outline-level:6;	font-size:12.0pt;	font-family:Times;	font-style:italic;}p.MsoHeader, li.MsoHeader, div.MsoHeader	{margin:0in;	margin-bottom:.0001pt;	mso-pagination:widow-orphan;	tab-stops:center 3.0in right 6.0in;	font-size:12.0pt;	font-family:Times;}p.MsoFooter, li.MsoFooter, div.MsoFooter	{margin:0in;	margin-bottom:.0001pt;	mso-pagination:widow-orphan;	tab-stops:center 3.0in right 6.0in;	font-size:12.0pt;	font-family:Times;}p.MsoBodyText, li.MsoBodyText, div.MsoBodyText	{margin:0in;	margin-bottom:.0001pt;	text-align:center;	mso-pagination:widow-orphan;	font-size:22.0pt;	font-family:Times;}p.MsoBodyTextIndent, li.MsoBodyTextIndent, div.MsoBodyTextIndent	{margin-top:0in;	margin-right:0in;	margin-bottom:0in;	margin-left:-27.0pt;	margin-bottom:.0001pt;	line-height:150%;	mso-pagination:widow-orphan;	font-size:12.0pt;	font-family:Times;}p.MsoBodyText2, li.MsoBodyText2, div.MsoBodyText2	{margin:0in;	margin-bottom:.0001pt;	line-height:150%;	mso-pagination:widow-orphan;	font-size:10.0pt;	font-family:Times;}p.MsoBodyText3, li.MsoBodyText3, div.MsoBodyText3	{margin:0in;	margin-bottom:.0001pt;	text-align:justify;	mso-pagination:widow-orphan;	mso-outline-level:1;	font-size:12.0pt;	font-family:Times;}p.MsoBodyTextIndent2, li.MsoBodyTextIndent2, div.MsoBodyTextIndent2	{margin-top:0in;	margin-right:0in;	margin-bottom:0in;	margin-left:-27.0pt;	margin-bottom:.0001pt;	text-align:justify;	line-height:150%;	mso-pagination:widow-orphan;	font-size:12.0pt;	font-family:Times;}a:link, span.MsoHyperlink	{color:blue;	text-decoration:underline;	text-underline:single;}a:visited, span.MsoHyperlinkFollowed	{color:purple;	text-decoration:underline;	text-underline:single;}p.MsoDocumentMap, li.MsoDocumentMap, div.MsoDocumentMap	{margin:0in;	margin-bottom:.0001pt;	mso-pagination:widow-orphan;	background:navy;	font-size:12.0pt;	font-family:Geneva;}table.MsoNormalTable	{mso-style-parent:"";	font-size:10.0pt;	font-family:Times;}@page Section1	{size:8.5in 11.0in;	margin:1.0in 1.0in 1.0in 1.0in;	mso-header-margin:.5in;	mso-footer-margin:.55in;	mso-page-numbers:1;	mso-title-page:yes;	mso-header:url(":INOS_EthSci_files:header.htm") h1;	mso-footer:url(":INOS_EthSci_files:header.htm") f1;	mso-first-footer:url(":INOS_EthSci_files:header.htm") ff1;	mso-paper-source:0;}div.Section1	{page:Section1;}--></style><!--[if gte mso 9]><xml> <o:shapedefaults v:ext="edit" spidmax="2050"/></xml><![endif]--><!--[if gte mso 9]><xml> <o:shapelayout v:ext="edit">  <o:idmap v:ext="edit" data="1"/> </o:shapelayout></xml><![endif]--></head><body bgcolor=white lang=EN-US link=blue vlink=purple style='tab-interval:.5in'><div class=Section1><p class=MsoBodyText><span style='font-size:16.0pt'><b>INOS 2008: EthicalScience or Something Else?</b></span><span style='font-size:20.0pt'><b><o:p></o:p></b></span></p><p class=MsoNormal style='text-align:justify'><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></p><p class=MsoBodyText><span style='font-size:14.0pt;font-family:"Times New Roman"'>L.F.Dell’Osso, Ph.D.<o:p></o:p></span></p><p class=MsoNormal align=center style='text-align:center;mso-outline-level:1'><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></p><p class=MsoNormal style='text-align:justify'><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></p><p class=MsoNormal style='text-align:justify'><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></p><p class=MsoBodyText align=left style='text-align:left'><span style='font-size:12.0pt'><b>OMLAB Editorial #071107<o:p></o:p></b></span></p><p class=MsoBodyText align=left style='text-align:left'><span style='font-size:12.0pt'><b>Written:</b></span><span style='font-size:12.0pt'> 7/7/07; <b>Placedon Web Page:</b></span><span style='font-size:12.0pt'> 7/11/07; <b>LastModified:</b></span><span style='font-size:12.0pt'> 8/6/08<o:p></o:p></span></p><p class=MsoBodyText align=left style='text-align:left'><span style='font-size:12.0pt'><b>Downloaded from:</b></span><span style='font-size:12.0pt'> OMLAB.ORG<o:p></o:p></span></p><p class=MsoNormal><b>Send questions, comments, and suggestions to:</b><spanstyle='font-weight:normal'> lfd@case.edu</span></p><p class=MsoBodyText3><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></p><p class=MsoNormal style='text-align:justify'><span style='font-size:11.0pt'>Foralmost two decades, I have supported and attended many INOS meetings all overthe world. In each of them, invited speakers were recognized authorities on thetopics of their presentations. However, in the program for INOS 2008 there hasbeen a radical departure that raises many questions and concerns both about thequalifications and objectivity of one invited speaker and a possible politicalagenda behind the invitation. These questions and concerns were communicated tothe person responsible for the invitation and were ignored; I was summarilyinformed that the invitation was a <i>fait accompli</i></span><spanstyle='font-size:11.0pt'>. In order to evaluate this presentation, the membersof INOS and others in the audience deserve disclosure about the qualificationsand possible lack of objectivity of the invited “expert” they are listening to.In the interests of such disclosure, I will address both in this editorial.<o:p></o:p></span></p><p class=MsoNormal><span style='font-size:11.0pt'><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></span></p><p class=MsoNormal><span style='font-size:11.0pt'><b>Qualifications<o:p></o:p></b></span></p><p class=MsoNormal><span style='font-size:11.0pt'>There are many respectedscientists whose research in the field of Infantile Nystagmus Syndrome (INS,aka CN) and its treatments is known to most members of INOS; some have decadesof experience and numerous publications of their results. Other, youngerscientists have also made significant contributions to this field. The personchosen to speak on “Does tenotomy work for CN and for acquired nystagmus?” doesnot appear on this list by any objective criteria. According to his CV, he onlyhas two minor publications involving the actual recording and analyzing of INSpatients; they were both “case-report” types of papers on a few atypicalpatients with vestibular symptoms and oscillopsia that were studied in the labof David Zee. Their publication dates were 1985 and 1989; there have been nopublications of any INS studies conducted by him in the past 18 years. Whythen, was Lance Optican invited to give an address at the INOS meeting on atopic in which he has no expertise and no apparent direct experience inrecording INS patients’ eye movements? It appears that he was chosen solely onthe basis of two papers published in Vision Research in 2003 </span><!--[if supportFields]><spanstyle='font-size:11.0pt'><span style='mso-element:field-begin'></span><spanstyle="mso-spacerun: yes">&nbsp;</span>ADDIN EN.CITE&lt;EndNote&gt;&lt;Cite&gt;&lt;Author&gt;Miura&lt;/Author&gt;&lt;Year&gt;2003&lt;/Year&gt;&lt;RecNum&gt;2&lt;/RecNum&gt;&lt;record&gt;&lt;rec-number&gt;2&lt;/rec-number&gt;&lt;ref-typename=&quot;JournalArticle&quot;&gt;17&lt;/ref-type&gt;&lt;contributors&gt;&lt;authors&gt;&lt;author&gt;Miura,K.&lt;/author&gt;&lt;author&gt;Hertle, R. W.&lt;/author&gt;&lt;author&gt;FitzGibbon,E. J.&lt;/author&gt;&lt;author&gt;Optican, L.M.&lt;/author&gt;&lt;/authors&gt;&lt;/contributors&gt;&lt;auth-address&gt;Laboratoryof Sensorimotor Research, National Eye Institute, National Institutes ofHealth, Bldg. 49, Rm. 2A50, 20892, Bethesda, MD, USA&lt;/auth-address&gt;&lt;titles&gt;&lt;title&gt;Effectsof tenotomy surgery on congenital nystagmus waveforms in adult patients. PartI. Wavelet spectral analysis&lt;/title&gt;&lt;secondary-title&gt;VisionRes&lt;/secondary-title&gt;&lt;/titles&gt;&lt;pages&gt;2345-56&lt;/pages&gt;&lt;volume&gt;43&lt;/volume&gt;&lt;number&gt;22&lt;/number&gt;&lt;keywords&gt;&lt;keyword&gt;CN:TENOT:SURG:&lt;/keyword&gt;&lt;/keywords&gt;&lt;dates&gt;&lt;year&gt;2003&lt;/year&gt;&lt;pub-dates&gt;&lt;date&gt;Oct&lt;/date&gt;&lt;/pub-dates&gt;&lt;/dates&gt;&lt;accession-num&gt;12962991&lt;/accession-num&gt;&lt;label&gt;5.167&lt;/label&gt;&lt;urls&gt;&lt;related-urls&gt;&lt;url&gt;http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Citation&amp;amp;list_uids=12962991&lt;/url&gt;&lt;/related-urls&gt;&lt;/urls&gt;&lt;/record&gt;&lt;/Cite&gt;&lt;Cite&gt;&lt;Author&gt;Miura&lt;/Author&gt;&lt;Year&gt;2003&lt;/Year&gt;&lt;RecNum&gt;3&lt;/RecNum&gt;&lt;record&gt;&lt;rec-number&gt;3&lt;/rec-number&gt;&lt;ref-typename=&quot;Journal Article&quot;&gt;17&lt;/ref-type&gt;&lt;contributors&gt;&lt;authors&gt;&lt;author&gt;Miura,K.&lt;/author&gt;&lt;author&gt;Hertle, R.W.&lt;/author&gt;&lt;author&gt;FitzGibbon, E.J.&lt;/author&gt;&lt;author&gt;Optican, L.M.&lt;/author&gt;&lt;/authors&gt;&lt;/contributors&gt;&lt;auth-address&gt;Laboratoryof Sensorimotor Research, National Eye Institute, National Institutes ofHealth, Bldg. 49, Rm. 2A50, 20892, Bethesda, MD,USA&lt;/auth-address&gt;&lt;titles&gt;&lt;title&gt;Effects of tenotomy surgeryon congenital nystagmus waveforms in adult patients. Part II. Dynamical systemsanalysis&lt;/title&gt;&lt;secondary-title&gt;Vision Res&lt;/secondary-title&gt;&lt;/titles&gt;&lt;pages&gt;2357-62&lt;/pages&gt;&lt;volume&gt;43&lt;/volume&gt;&lt;number&gt;22&lt;/number&gt;&lt;keywords&gt;&lt;keyword&gt;CN:TENOT:SURG:&lt;/keyword&gt;&lt;/keywords&gt;&lt;dates&gt;&lt;year&gt;2003&lt;/year&gt;&lt;pub-dates&gt;&lt;date&gt;Oct&lt;/date&gt;&lt;/pub-dates&gt;&lt;/dates&gt;&lt;accession-num&gt;12962992&lt;/accession-num&gt;&lt;label&gt;5.168&lt;/label&gt;&lt;urls&gt;&lt;related-urls&gt;&lt;url&gt;http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Citation&amp;amp;list_uids=12962992&lt;/url&gt;&lt;/related-urls&gt;&lt;/urls&gt;&lt;/record&gt;&lt;/Cite&gt;&lt;/EndNote&gt;<spanstyle='mso-element:field-separator'></span></span><![endif]--><spanstyle='font-size:11.0pt'>(1,2)</span><!--[if supportFields]><spanstyle='font-size:11.0pt'><span style='mso-element:field-end'></span></span><![endif]--><spanstyle='font-size:11.0pt'>. These papers are the crux of the matter. There aretwo issues involved: 1) their scientific merit and 2) their history, detailingthe methods used by the responsible authors to acquire and use the data ofothers during an ongoing masked-data NEI clinical trial (i.e., the possibilityof deception and bias). The first falls under “Qualifications” and the latterunder “Objectivity” <o:p></o:p></span></p><p class=MsoNormal><span style='font-size:11.0pt'><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></span></p><p class=MsoNormal><span style='font-size:11.0pt'><i>Scientific Merit<o:p></o:p></i></span></p><p class=MsoNormal><span style='font-size:11.0pt'>The major conclusions in therespective abstracts of the above two papers were: 1) “tenotomy surgery has noeffect, or only a quite small effect, on the waveform structure of CN” and 2)“tenotomy has no effect, or only a quite small effect, on the underlyingmechanism of the CN beats.” To many who read the abstracts, these carefullyworded (“only a quite small effect”) but unsupported conclusions cast doubt on thepositive findings of the masked-data NEI clinical trial of the effectiveness ofthe tenotomy procedure. Most readers did not have the background to understandthe complex mathematics underlying both methods. First, neither of the twomethods (wavelets or dynamical systems analysis) was demonstrated to be <i>sensitive</i></span><spanstyle='font-size:11.0pt'> enough to detect the NAFX-measurable foveationimprovements produced by tenotomy; not in those papers nor in any to be foundin the literature, before or since. Second, analysis of the papers revealedserious methodological errors in the application of the analysis methods and inthe data handling; the responsible authors had limited experience in both.Third, additional errors remained undetected until after publication of myletter to the editor of Vision Research outlining the problems detected fromthe papers alone and concluding that their poor methodology effectivelyprecluded and made moot the conclusions of the papers </span><!--[if supportFields]><spanstyle='font-size:11.0pt'><span style='mso-element:field-begin'></span><spanstyle="mso-spacerun: yes">&nbsp;</span>ADDIN EN.CITE&lt;EndNote&gt;&lt;Cite&gt;&lt;Author&gt;Dell&amp;apos;Osso&lt;/Author&gt;&lt;Year&gt;2004&lt;/Year&gt;&lt;RecNum&gt;4&lt;/RecNum&gt;&lt;record&gt;&lt;rec-number&gt;4&lt;/rec-number&gt;&lt;ref-typename=&quot;JournalArticle&quot;&gt;17&lt;/ref-type&gt;&lt;contributors&gt;&lt;authors&gt;&lt;author&gt;Dell&amp;apos;Osso,L. F.&lt;/author&gt;&lt;/authors&gt;&lt;/contributors&gt;&lt;titles&gt;&lt;title&gt;Tenotomyand congenital nystagmus: a failure to answer the wrongquestion&lt;/title&gt;&lt;secondary-title&gt;VisionRes&lt;/secondary-title&gt;&lt;/titles&gt;&lt;pages&gt;3091-3094&lt;/pages&gt;&lt;volume&gt;44&lt;/volume&gt;&lt;keywords&gt;&lt;keyword&gt;CN:TENOT: SURG: wavelets: dynamical systems analysis:&lt;/keyword&gt;&lt;/keywords&gt;&lt;dates&gt;&lt;year&gt;2004&lt;/year&gt;&lt;/dates&gt;&lt;label&gt;5.169&lt;/label&gt;&lt;urls&gt;&lt;/urls&gt;&lt;/record&gt;&lt;/Cite&gt;&lt;/EndNote&gt;<spanstyle='mso-element:field-separator'></span></span><![endif]--><spanstyle='font-size:11.0pt'>(3)</span><!--[if supportFields]><spanstyle='font-size:11.0pt'><span style='mso-element:field-end'></span></span><![endif]--><spanstyle='font-size:11.0pt'>. Optican’s response letter </span><!--[if supportFields]><spanstyle='font-size:11.0pt'><span style='mso-element:field-begin'></span><spanstyle="mso-spacerun: yes">&nbsp;</span>ADDIN EN.CITE&lt;EndNote&gt;&lt;Cite&gt;&lt;Author&gt;Optican&lt;/Author&gt;&lt;Year&gt;2004&lt;/Year&gt;&lt;RecNum&gt;5&lt;/RecNum&gt;&lt;record&gt;&lt;rec-number&gt;5&lt;/rec-number&gt;&lt;ref-typename=&quot;Journal Article&quot;&gt;17&lt;/ref-type&gt;&lt;contributors&gt;&lt;authors&gt;&lt;author&gt;Optican,L. M.&lt;/author&gt;&lt;author&gt;Miura,K.&lt;/author&gt;&lt;author&gt;FitzGibbon, E.J.&lt;/author&gt;&lt;/authors&gt;&lt;/contributors&gt;&lt;titles&gt;&lt;title&gt;Tenotomyand congenital nystagmus: a null result is not a failure, for &amp;quot;It isnot the answer that enlightens, but thequestion&amp;quot;&lt;/title&gt;&lt;secondary-title&gt;VisionRes&lt;/secondary-title&gt;&lt;/titles&gt;&lt;pages&gt;3095-3098&lt;/pages&gt;&lt;volume&gt;44&lt;/volume&gt;&lt;keywords&gt;&lt;keyword&gt;CN:TENOT: SURG: wavelets: dynamical systemsanalysis:&lt;/keyword&gt;&lt;/keywords&gt;&lt;dates&gt;&lt;year&gt;2004&lt;/year&gt;&lt;/dates&gt;&lt;label&gt;5.178&lt;/label&gt;&lt;urls&gt;&lt;/urls&gt;&lt;/record&gt;&lt;/Cite&gt;&lt;/EndNote&gt;<spanstyle='mso-element:field-separator'></span></span><![endif]--><spanstyle='font-size:11.0pt'>(4)</span><!--[if supportFields]><spanstyle='font-size:11.0pt'><span style='mso-element:field-end'></span></span><![endif]--><spanstyle='font-size:11.0pt'> failed to persuasively address the methodologicalerrors but rather contained personal attacks not only related to the NEIclinical trial but also, all of the prior work by my colleagues and me,including the canines with achiasma and INS. None of these were the subject ofmy letter. Specific rebuttal to the issues brought up in the response lettermay be found elsewhere </span><!--[if supportFields]><span style='mso-element:field-begin'></span><span style="mso-spacerun: yes">&nbsp;</span>ADDIN EN.CITE&lt;EndNote&gt;&lt;Cite&gt;&lt;Author&gt;Dell&amp;apos;Osso&lt;/Author&gt;&lt;Year&gt;2007&lt;/Year&gt;&lt;RecNum&gt;13&lt;/RecNum&gt;&lt;record&gt;&lt;rec-number&gt;13&lt;/rec-number&gt;&lt;ref-typename=&quot;ElectronicArticle&quot;&gt;43&lt;/ref-type&gt;&lt;contributors&gt;&lt;authors&gt;&lt;author&gt;Dell&amp;apos;Osso,L.F.&lt;/author&gt;&lt;/authors&gt;&lt;/contributors&gt;&lt;titles&gt;&lt;title&gt;Respondingto more than a response: tenotomyworks&lt;/title&gt;&lt;secondary-title&gt;OMLABReport&lt;/secondary-title&gt;&lt;/titles&gt;&lt;periodical&gt;&lt;full-title&gt;OMLABReport&lt;/full-title&gt;&lt;/periodical&gt;&lt;pages&gt;1-x&lt;/pages&gt;&lt;volume&gt;#062x07&lt;/volume&gt;&lt;keywords&gt;&lt;keyword&gt;CN:NAFX: THPY: SURG:&lt;/keyword&gt;&lt;/keywords&gt;&lt;dates&gt;&lt;year&gt;2007&lt;/year&gt;&lt;/dates&gt;&lt;label&gt;5.253&lt;/label&gt;&lt;urls&gt;&lt;related-urls&gt;&lt;url&gt;&lt;styleface=&quot;underline&quot; font=&quot;default&quot;size=&quot;100%&quot;&gt;http://www.omlab.org/OMLAB_page/Teaching/teaching.html&lt;/style&gt;&lt;/url&gt;&lt;/related-urls&gt;&lt;/urls&gt;&lt;/record&gt;&lt;/Cite&gt;&lt;/EndNote&gt;<spanstyle='mso-element:field-separator'></span><![endif]-->(5)<!--[if supportFields]><spanstyle='mso-element:field-end'></span><![endif]--><span style='font-size:11.0pt'>.With no foundation, he also questioned the objectivity of the NAFX and itsapplication.<o:p></o:p></span></p><p class=MsoNormal><span style='font-size:11.0pt'><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></span></p><p class=MsoNormal><span style='font-size:11.0pt'>The NAFX has been used in theDaroff-Dell’Osso Ocular Motility Laboratory for over a decade and itssensitivity to waveform changes directly affecting visual acuity had been repeatedlydemonstrated and published for all waveforms in patients with and withoutafferent visual deficits. It is applied to the fixating eye during intervalsfree of recording artifact (e.g., blinks, switch of fixation to the other eye,loss of attention/fixation, switch in fixation elsewhere, etc.). This is commonpractice (indeed, essential) in eye-movement research and is easily done by anyone after some training and experience. The NAFX does require that the data beaccurately <i>calibrated</i></span><span style='font-size:11.0pt'> so eyeposition is known. The efficacy of the NAFX has also been demonstrated by otherresearchers applying it and obtaining results equivalent to ours; they used theNAFX to predict visual acuities because it <i>exceeded all other measures</i></span><spanstyle='font-size:11.0pt'> in correlating with visual acuity </span><!--[if supportFields]><spanstyle='font-size:11.0pt'><span style='mso-element:field-begin'></span><spanstyle="mso-spacerun: yes">&nbsp;</span>ADDIN EN.CITE&lt;EndNote&gt;&lt;Cite&gt;&lt;Author&gt;Sarvananthan&lt;/Author&gt;&lt;Year&gt;2006&lt;/Year&gt;&lt;RecNum&gt;7&lt;/RecNum&gt;&lt;record&gt;&lt;rec-number&gt;7&lt;/rec-number&gt;&lt;ref-typename=&quot;JournalArticle&quot;&gt;17&lt;/ref-type&gt;&lt;contributors&gt;&lt;authors&gt;&lt;author&gt;Sarvananthan,N.&lt;/author&gt;&lt;author&gt;Proudlock, F. A.&lt;/author&gt;&lt;author&gt;Choudhuri,I.&lt;/author&gt;&lt;author&gt;Dua, H.&lt;/author&gt;&lt;author&gt;Gottlob,I.&lt;/author&gt;&lt;/authors&gt;&lt;/contributors&gt;&lt;auth-address&gt;Departmentof Ophthalmology, Faculty of Medicine and Biological Sciences, The LeicesterRoyal Infirmary, England. nagini@pathmanathan.com&lt;/auth-address&gt;&lt;titles&gt;&lt;title&gt;Pharmacologictreatment of congenital nystagmus&lt;/title&gt;&lt;secondary-title&gt;ArchOphthalmol&lt;/secondary-title&gt;&lt;/titles&gt;&lt;pages&gt;916-8&lt;/pages&gt;&lt;volume&gt;124&lt;/volume&gt;&lt;number&gt;6&lt;/number&gt;&lt;keywords&gt;&lt;keyword&gt;CN:NAFX: THPY: VACTY: drug:&lt;/keyword&gt;&lt;keyword&gt;Administration,Oral&lt;/keyword&gt;&lt;keyword&gt;Adult&lt;/keyword&gt;&lt;keyword&gt;Amines/*therapeuticuse&lt;/keyword&gt;&lt;keyword&gt;Cyclohexanecarboxylic Acids/*therapeuticuse&lt;/keyword&gt;&lt;keyword&gt;Excitatory Amino AcidAntagonists/*therapeutic use&lt;/keyword&gt;&lt;keyword&gt;EyeMovements&lt;/keyword&gt;&lt;keyword&gt;Humans&lt;/keyword&gt;&lt;keyword&gt;Male&lt;/keyword&gt;&lt;keyword&gt;Nystagmus,Congenital/*drug therapy&lt;/keyword&gt;&lt;keyword&gt;VisualAcuity&lt;/keyword&gt;&lt;keyword&gt;gamma-Aminobutyric Acid/*therapeuticuse&lt;/keyword&gt;&lt;/keywords&gt;&lt;dates&gt;&lt;year&gt;2006&lt;/year&gt;&lt;pub-dates&gt;&lt;date&gt;Jun&lt;/date&gt;&lt;/pub-dates&gt;&lt;/dates&gt;&lt;accession-num&gt;16769853&lt;/accession-num&gt;&lt;label&gt;5.240&lt;/label&gt;&lt;urls&gt;&lt;related-urls&gt;&lt;url&gt;&lt;styleface=&quot;underline&quot; font=&quot;default&quot;size=&quot;100%&quot;&gt;http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Citation&amp;amp;list_uids=16769853&lt;/style&gt;&lt;/url&gt;&lt;/related-urls&gt;&lt;/urls&gt;&lt;/record&gt;&lt;/Cite&gt;&lt;/EndNote&gt;<spanstyle='mso-element:field-separator'></span></span><![endif]--><spanstyle='font-size:11.0pt'>(6)</span><!--[if supportFields]><spanstyle='font-size:11.0pt'><span style='mso-element:field-end'></span></span><![endif]--><spanstyle='font-size:11.0pt'>. Because of its accuracy in predicting visual acuity,the NAFX has also been used to estimate post-therapy improvements in INS andacquired nystagmus patients independently of any afferent deficits </span><!--[if supportFields]><spanstyle='font-size:11.0pt'><span style='mso-element:field-begin'></span><spanstyle="mso-spacerun: yes">&nbsp;</span>ADDIN EN.CITE&lt;EndNote&gt;&lt;Cite&gt;&lt;Author&gt;Tomsak&lt;/Author&gt;&lt;Year&gt;2005&lt;/Year&gt;&lt;RecNum&gt;12&lt;/RecNum&gt;&lt;record&gt;&lt;rec-number&gt;12&lt;/rec-number&gt;&lt;ref-typename=&quot;JournalArticle&quot;&gt;17&lt;/ref-type&gt;&lt;contributors&gt;&lt;authors&gt;&lt;author&gt;Tomsak,R. L.&lt;/author&gt;&lt;author&gt;Dell&amp;apos;Osso, L.F.&lt;/author&gt;&lt;author&gt;Rucker, J. C.&lt;/author&gt;&lt;author&gt;Leigh,R. J.&lt;/author&gt;&lt;author&gt;Bienfang, D.C.&lt;/author&gt;&lt;author&gt;Jacobs, J. B.&lt;/author&gt;&lt;/authors&gt;&lt;/contributors&gt;&lt;titles&gt;&lt;title&gt;Treatmentof acquired pendular nystagmus from multiple sclerosis with eye muscle surgeryfollowed by oralmemantine&lt;/title&gt;&lt;secondary-title&gt;DJO&lt;/secondary-title&gt;&lt;/titles&gt;&lt;periodical&gt;&lt;full-title&gt;DJO&lt;/full-title&gt;&lt;/periodical&gt;&lt;pages&gt;1-11&lt;/pages&gt;&lt;volume&gt;11&lt;/volume&gt;&lt;number&gt;4&lt;/number&gt;&lt;keywords&gt;&lt;keyword&gt;Tenotomy:NAFX: APN: MS:drug:&lt;/keyword&gt;&lt;/keywords&gt;&lt;dates&gt;&lt;year&gt;2005&lt;/year&gt;&lt;/dates&gt;&lt;label&gt;5.224&lt;/label&gt;&lt;urls&gt;&lt;/urls&gt;&lt;/record&gt;&lt;/Cite&gt;&lt;Cite&gt;&lt;Author&gt;Wang&lt;/Author&gt;&lt;Year&gt;2006&lt;/Year&gt;&lt;RecNum&gt;10&lt;/RecNum&gt;&lt;record&gt;&lt;rec-number&gt;10&lt;/rec-number&gt;&lt;ref-typename=&quot;Journal Article&quot;&gt;17&lt;/ref-type&gt;&lt;contributors&gt;&lt;authors&gt;&lt;author&gt;Wang,Z.&lt;/author&gt;&lt;author&gt;Dell&amp;apos;Osso, L.F.&lt;/author&gt;&lt;author&gt;Jacobs, J.B.&lt;/author&gt;&lt;author&gt;Burnstine, R. A.&lt;/author&gt;&lt;author&gt;Tomsak,R.L.&lt;/author&gt;&lt;/authors&gt;&lt;/contributors&gt;&lt;titles&gt;&lt;title&gt;Effectsof tenotomy on patients with infantile nystagmus syndrome: foveationimprovement over a broadened visualfield&lt;/title&gt;&lt;secondary-title&gt;JAAPOS&lt;/secondary-title&gt;&lt;/titles&gt;&lt;periodical&gt;&lt;full-title&gt;JAAPOS&lt;/full-title&gt;&lt;/periodical&gt;&lt;pages&gt;552-560&lt;/pages&gt;&lt;volume&gt;10&lt;/volume&gt;&lt;keywords&gt;&lt;keyword&gt;CN:SURG: TENOT: NAFX:LFD:&lt;/keyword&gt;&lt;/keywords&gt;&lt;dates&gt;&lt;year&gt;2006&lt;/year&gt;&lt;/dates&gt;&lt;label&gt;5.243&lt;/label&gt;&lt;urls&gt;&lt;/urls&gt;&lt;/record&gt;&lt;/Cite&gt;&lt;Cite&gt;&lt;Author&gt;Wang&lt;/Author&gt;&lt;Year&gt;2007&lt;/Year&gt;&lt;RecNum&gt;11&lt;/RecNum&gt;&lt;record&gt;&lt;rec-number&gt;11&lt;/rec-number&gt;&lt;ref-typename=&quot;JournalArticle&quot;&gt;17&lt;/ref-type&gt;&lt;contributors&gt;&lt;authors&gt;&lt;author&gt;Wang,Z. I.&lt;/author&gt;&lt;author&gt;Dell&amp;apos;Osso, L.F.&lt;/author&gt;&lt;author&gt;Tomsak, R.L.&lt;/author&gt;&lt;author&gt;Jacobs, J. B.&lt;/author&gt;&lt;/authors&gt;&lt;/contributors&gt;&lt;titles&gt;&lt;title&gt;Combiningrecessions (nystagmus and strabismus) with tenotomy improved visual functionand decreased oscillopsia and diplopia in acquired downbeat nystagmus and inhorizontal infantile nystagmussyndrome&lt;/title&gt;&lt;secondary-title&gt;JAAPOS&lt;/secondary-title&gt;&lt;/titles&gt;&lt;periodical&gt;&lt;full-title&gt;JAAPOS&lt;/full-title&gt;&lt;/periodical&gt;&lt;pages&gt;135-141&lt;/pages&gt;&lt;volume&gt;11&lt;/volume&gt;&lt;keywords&gt;&lt;keyword&gt;CN:SURG: DBN: AN:OSOP:&lt;/keyword&gt;&lt;/keywords&gt;&lt;dates&gt;&lt;year&gt;2007&lt;/year&gt;&lt;/dates&gt;&lt;label&gt;5.249&lt;/label&gt;&lt;urls&gt;&lt;/urls&gt;&lt;/record&gt;&lt;/Cite&gt;&lt;/EndNote&gt;<spanstyle='mso-element:field-separator'></span></span><![endif]--><spanstyle='font-size:11.0pt'>(7-9)</span><!--[if supportFields]><spanstyle='font-size:11.0pt'><span style='mso-element:field-end'></span></span><![endif]--><spanstyle='font-size:11.0pt'>. To specifically ensure that the method was both <i>repeatable</i></span><spanstyle='font-size:11.0pt'> and <i>objective,</i></span><span style='font-size:11.0pt'> not only was the NAFX analysis in the NEI clinical trial conducted on <i>masked</i></span><spanstyle='font-size:11.0pt'> data but also on <i>redundant masked data files</i></span><spanstyle='font-size:11.0pt'> that were sent to me for analysis. Optican failed toreport this critical information in either his papers or response.Significantly, there was no such protection in Optican’s “playing” (see below)with our data; he also failed to report that he drew his conclusions fromunmasked data files whose only purpose was to uncover asymmetric aperiodicalternating nystagmus.<o:p></o:p></span></p><p class=MsoNormal><span style='font-size:11.0pt'><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></span></p><p class=MsoNormal><span style='font-size:11.0pt'>Optican’s response letterseemed to reveal ignorance of basic concepts involved in the calibration andanalysis of INS data; it is necessary to accurately calibrate data if one is toanalyze it properly. The<s> </s>additional errors revealed in the responsefurther invalidated both studies and, in response to a reviewer’s <i>specific</i></span><spanstyle='font-size:11.0pt'> request, were addressed in a subsequent publicationon the beneficial “small-signal” effects of tenotomy </span><!--[if supportFields]><spanstyle='font-size:11.0pt'><span style='mso-element:field-begin'></span><spanstyle="mso-spacerun: yes">&nbsp;</span>ADDIN EN.CITE&lt;EndNote&gt;&lt;Cite&gt;&lt;Author&gt;Wang&lt;/Author&gt;&lt;Year&gt;2006&lt;/Year&gt;&lt;RecNum&gt;6&lt;/RecNum&gt;&lt;record&gt;&lt;rec-number&gt;6&lt;/rec-number&gt;&lt;ref-typename=&quot;JournalArticle&quot;&gt;17&lt;/ref-type&gt;&lt;contributors&gt;&lt;authors&gt;&lt;author&gt;Wang,Z.&lt;/author&gt;&lt;author&gt;Dell&amp;apos;Osso, L.F.&lt;/author&gt;&lt;author&gt;Zhang, Z.&lt;/author&gt;&lt;author&gt;Leigh, R.J.&lt;/author&gt;&lt;author&gt;Jacobs, J.B.&lt;/author&gt;&lt;/authors&gt;&lt;/contributors&gt;&lt;auth-address&gt;Daroff-Dell&amp;apos;OssoOcular Motility Laboratory, Louis Stokes Cleveland Department of VeteransAffairs Medical Center, Cleveland, OH, USA; Department of BiomedicalEngineering, Case Western Reserve University and University Hospitals ofCleveland, Cleveland, OH,USA.&lt;/auth-address&gt;&lt;titles&gt;&lt;title&gt;Tenotomy does not affectsaccadic velocities: Support for the &amp;quot;small-signal&amp;quot; gainhypothesis&lt;/title&gt;&lt;secondary-title&gt;Vision Res&lt;/secondary-title&gt;&lt;/titles&gt;&lt;pages&gt;2259-2267&lt;/pages&gt;&lt;volume&gt;46&lt;/volume&gt;&lt;keywords&gt;&lt;keyword&gt;Tenotomy:sacc: vel: NAFX: SURG: PLNT:NYST:&lt;/keyword&gt;&lt;/keywords&gt;&lt;dates&gt;&lt;year&gt;2006&lt;/year&gt;&lt;/dates&gt;&lt;accession-num&gt;16497352&lt;/accession-num&gt;&lt;label&gt;5.223&lt;/label&gt;&lt;urls&gt;&lt;related-urls&gt;&lt;url&gt;http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Citation&amp;amp;list_uids=16497352&lt;/url&gt;&lt;/related-urls&gt;&lt;/urls&gt;&lt;/record&gt;&lt;/Cite&gt;&lt;/EndNote&gt;<spanstyle='mso-element:field-separator'></span></span><![endif]--><spanstyle='font-size:11.0pt'>(10)</span><!--[if supportFields]><spanstyle='font-size:11.0pt'><span style='mso-element:field-end'></span></span><![endif]--><spanstyle='font-size:11.0pt'>. Optican and Miura indicated in their response thatthey found it <i>difficult</i></span><span style='font-size:11.0pt'> tocalibrate the cleanly recorded search-coil data from our NEI clinical trial,data that I easily calibrated despite being masked! It is not surprising thatsuch inexperience needed the shield of coauthors with some expertise inrecording and analyzing INS data; it is unfortunate that their expertise wasnot evident in the papers. Hertle’s verbal warning that Optican and Miurashould not choose long, uncontrolled and artifact-filled files for analysis,was ignored; he, and I, assumed that Optican and Miura accurately calibratedthe data they analyzed. Even if all of the methodological errors were correctedand the same failure to find a difference occurred, the only supportableconclusion that could be drawn from the wavelet paper would be that the method <i>didnot detect</i></span><span style='font-size:11.0pt'> the tenotomy-producedwaveform changes that were measured by the NAFX and resulted in improved visualfunction. The authors could not conclude there were no changes. Unlike theNAFX, wavelet analysis has never been proven to be a definitive measure of thespecific waveform changes in question; it has not been proven to be a measureat all. From the dynamical systems analysis paper, The authors’ conclusion thattenotomy does not appear to affect the underlying mechanism of INS applies onlyif INS was caused by one mechanism; our data suggest that is not the case.However, tenotomy was never claimed to have affected INS mechanisms but rather,that it improved the resulting INS waveforms, a <i>critical</i></span><spanstyle='font-size:11.0pt'> difference that also was omitted.<o:p></o:p></span></p><p class=MsoNormal><span style='font-size:11.0pt'><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></span></p><p class=MsoNormal><span style='font-size:11.0pt'>The bottom line is, those twopapers cannot even support the null conclusions of their authors because of theapparently insensitive methods, applied in violation of their underlyingmathematical principals, coupled with improper data choices and failure to accuratelycalibrate the data. I found them devoid of scientific value; they should havebeen rejected on merit alone. Perhaps an analogy will help clarify thescientific fallacy of the two papers. Consider if one used a Gieger counter tomeasure the pre- and post-tenotomy radiation given off by the patients’ eyesand found no difference. This is also a sensitive method designed for othertasks. No careful scientist would conclude from such a null finding thattenotomy did not affect the eye movements. In both my letter to Vision Researchand the “small-signal” paper, my harsh (and, in the letter, intense) criticismof the two papers in question concentrated solely on the obviously bad scienceand did not expose the ethical problems raised by the surreptitious data miningthat enabled them (see below). Apparently, my expectation that demonstratingtheir lack of scientific merit would suffice was misplaced.<spanstyle="mso-spacerun: yes">&nbsp; </span><o:p></o:p></span></p><p class=MsoNormal><span style='font-size:11.0pt'><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></span></p><p class=MsoNormal><span style='font-size:11.0pt'><b>Objectivity<o:p></o:p></b></span></p><p class=MsoNormal><span style='font-size:11.0pt'>We all presume an invitedspeaker to a prestigious meeting is both presenting his data objectively andthat he followed the normally accepted protocols associated with ethicalscience in acquiring and analyzing it. Unlike evaluating one’s qualificationsand publications, which are a matter of public record, detecting possible biasis more difficult and proving it, almost impossible. However, deviations fromthe norm, or actions that raise ethical concerns, are red flags that shouldwarn of the possible absence of objectivity, the foundation of scientificinquiry. Knowledge of them requires responsible scientists to at least,disclose them allowing more objective evaluation of the presentation.<o:p></o:p></span></p><p class=MsoNormal><span style='font-size:11.0pt'><span style="mso-spacerun:yes">&nbsp; </span><o:p></o:p></span></p><p class=MsoNormal><span style='font-size:11.0pt'><i>History<o:p></o:p></i></span></p><p class=MsoNormal><span style='font-size:11.0pt'>After Rich Hertle and Idemonstrated (1998) and published (1999) the positive effects of tenotomy onthe nystagmus waveforms of a canine, we began to study the INS waveform changesproduced by tenotomy in humans. We recruited Bob Burnstine to provide anotherclinical site and source of patients. It was during that time that the NEIrecruited Hertle from Philadelphia and, after he arrived there, we submittedour protocol for a clinical trial of tenotomy. I provided the ocular motilityprotocol and was the investigator in charge of performing all the motilityanalyses; the NAFX evaluation of INS waveform changes was the <i>primaryoutcome measure</i></span><span style='font-size:11.0pt'>, visual functionmeasures were <i>secondary</i></span><span style='font-size:11.0pt'>. It wasdecided that the data would be masked. I was given assurances that the maskingwould be carefully controlled to avoid any mislabeling of data. I was alsoassured that during the time I would be masked from the data and we publishedour results, no one outside of our research team would have access to our data.That assurance was to be violated by Optican from early on in our clinicaltrial and continue throughout its course.<o:p></o:p></span></p><p class=MsoNormal><span style='font-size:11.0pt'><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></span></p><p class=MsoNormal><span style='font-size:11.0pt'>At some point before theprotocol was approved (August 16, 1999), the NEI head (Carl Kupfer) attemptedto exclude me from the project, despite the fact that this project was based onmy prediction and subsequent demonstration of the beneficial effects oftenotomy, was initiated before the NEI was involved, and required my expertisein nystagmus analysis to provide the primary outcome results. Hertle preventedthis blatant attempt to hijack our joint work and place it entirely within theNEI.<o:p></o:p></span></p><p class=MsoNormal><span style='font-size:11.0pt'><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></span></p><p class=MsoNormal><span style='font-size:11.0pt'>On April 19, 2001, while inthe middle of my masked-data analysis, Hertle sent me a SFN abstract preparedby “K. Miura” and “L.M. Optican” at the NEI; they had accessed our unmaskeddata and used it for a study of the dynamical systems analysis of nystagmuswaveforms pre- and post-tenotomy. The abstract was sent to Hertle and EdFitzGibbon with two extra places allotted for authors filled with “??????,”prompting them to add their names as co-authors; this, despite the fact thatthe work was done by Optican and Miura. Earlier, Optican had assured Hertlethat his interest was not in the effects of tenotomy on INS (the subject of theNEI clinical trial) but in underlying mechanisms of INS. I immediatelyprotested this violation of the data- and patient-protection agreements thatensured my participation in the clinical trial. I was assured: 1) Optican hadviolated the NEI DSMC guidelines; 2) the improper behavior would be stopped;and 3) Optican would not be allowed to submit the abstract. Indeed, he wasprevented from doing so. Optican claimed he was only “playing with” our data(documented by email). I was then reassured that the data would not be sharedwith any one until our publication of the results of the clinical trial. Thus,during the three years I attended to the mind-numbing task of analyzing amountain of masked data, I was under the illusion that our data were beingprotected by the NEI from unauthorized eyes, and use, until publication of ourresults.<o:p></o:p></span></p><p class=MsoNormal><span style='font-size:11.0pt'><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></span></p><p class=MsoNormal><span style='font-size:11.0pt'>That illusion was shatteredwhen, about the <i>same time</i></span><span style='font-size:11.0pt'> as ourfirst publication demonstrating unequivocally the beneficial effects oftenotomy on INS waveforms </span><!--[if supportFields]><span style='font-size:11.0pt'><span style='mso-element:field-begin'></span><span style="mso-spacerun:yes">&nbsp;</span>ADDIN EN.CITE&lt;EndNote&gt;&lt;Cite&gt;&lt;Author&gt;Hertle&lt;/Author&gt;&lt;Year&gt;2003&lt;/Year&gt;&lt;RecNum&gt;1&lt;/RecNum&gt;&lt;record&gt;&lt;rec-number&gt;1&lt;/rec-number&gt;&lt;ref-typename=&quot;JournalArticle&quot;&gt;17&lt;/ref-type&gt;&lt;contributors&gt;&lt;authors&gt;&lt;author&gt;Hertle,R. W.&lt;/author&gt;&lt;author&gt;Dell&amp;apos;Osso, L.F.&lt;/author&gt;&lt;author&gt;FitzGibbon, E.J.&lt;/author&gt;&lt;author&gt;Thompson, D.&lt;/author&gt;&lt;author&gt;Yang,D.&lt;/author&gt;&lt;author&gt;Mellow, S. D.&lt;/author&gt;&lt;/authors&gt;&lt;/contributors&gt;&lt;titles&gt;&lt;title&gt;Horizontalrectus tenotomy in patients with congenital nystagmus. Results in 10adults&lt;/title&gt;&lt;secondary-title&gt;Ophthalmology&lt;/secondary-title&gt;&lt;/titles&gt;&lt;pages&gt;2097-2105&lt;/pages&gt;&lt;volume&gt;110&lt;/volume&gt;&lt;keywords&gt;&lt;keyword&gt;CN:SURG: TENOT:NAFX:&lt;/keyword&gt;&lt;/keywords&gt;&lt;dates&gt;&lt;year&gt;2003&lt;/year&gt;&lt;/dates&gt;&lt;label&gt;5.147&lt;/label&gt;&lt;urls&gt;&lt;/urls&gt;&lt;/record&gt;&lt;/Cite&gt;&lt;/EndNote&gt;<spanstyle='mso-element:field-separator'></span></span><![endif]--><spanstyle='font-size:11.0pt'>(11)</span><!--[if supportFields]><spanstyle='font-size:11.0pt'><span style='mso-element:field-end'></span></span><![endif]--><spanstyle='font-size:11.0pt'>, the two companion papers discussed above appeared inVision Research authored by Optican and Miura plus both of their NEIcolleagues; the papers claimed that tenotomy had no effects on INS waveforms </span><!--[if supportFields]><spanstyle='font-size:11.0pt'><span style='mso-element:field-begin'></span><spanstyle="mso-spacerun: yes">&nbsp;</span>ADDIN EN.CITE&lt;EndNote&gt;&lt;Cite&gt;&lt;Author&gt;Miura&lt;/Author&gt;&lt;Year&gt;2003&lt;/Year&gt;&lt;RecNum&gt;2&lt;/RecNum&gt;&lt;record&gt;&lt;rec-number&gt;2&lt;/rec-number&gt;&lt;ref-typename=&quot;JournalArticle&quot;&gt;17&lt;/ref-type&gt;&lt;contributors&gt;&lt;authors&gt;&lt;author&gt;Miura,K.&lt;/author&gt;&lt;author&gt;Hertle, R. W.&lt;/author&gt;&lt;author&gt;FitzGibbon,E. J.&lt;/author&gt;&lt;author&gt;Optican, L.M.&lt;/author&gt;&lt;/authors&gt;&lt;/contributors&gt;&lt;auth-address&gt;Laboratoryof Sensorimotor Research, National Eye Institute, National Institutes ofHealth, Bldg. 49, Rm. 2A50, 20892, Bethesda, MD, USA&lt;/auth-address&gt;&lt;titles&gt;&lt;title&gt;Effectsof tenotomy surgery on congenital nystagmus waveforms in adult patients. PartI. Wavelet spectral analysis&lt;/title&gt;&lt;secondary-title&gt;VisionRes&lt;/secondary-title&gt;&lt;/titles&gt;&lt;pages&gt;2345-56&lt;/pages&gt;&lt;volume&gt;43&lt;/volume&gt;&lt;number&gt;22&lt;/number&gt;&lt;keywords&gt;&lt;keyword&gt;CN:TENOT:SURG:&lt;/keyword&gt;&lt;/keywords&gt;&lt;dates&gt;&lt;year&gt;2003&lt;/year&gt;&lt;pub-dates&gt;&lt;date&gt;Oct&lt;/date&gt;&lt;/pub-dates&gt;&lt;/dates&gt;&lt;accession-num&gt;12962991&lt;/accession-num&gt;&lt;label&gt;5.167&lt;/label&gt;&lt;urls&gt;&lt;related-urls&gt;&lt;url&gt;http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Citation&amp;amp;list_uids=12962991&lt;/url&gt;&lt;/related-urls&gt;&lt;/urls&gt;&lt;/record&gt;&lt;/Cite&gt;&lt;Cite&gt;&lt;Author&gt;Miura&lt;/Author&gt;&lt;Year&gt;2003&lt;/Year&gt;&lt;RecNum&gt;3&lt;/RecNum&gt;&lt;record&gt;&lt;rec-number&gt;3&lt;/rec-number&gt;&lt;ref-typename=&quot;Journal Article&quot;&gt;17&lt;/ref-type&gt;&lt;contributors&gt;&lt;authors&gt;&lt;author&gt;Miura,K.&lt;/author&gt;&lt;author&gt;Hertle, R.W.&lt;/author&gt;&lt;author&gt;FitzGibbon, E.J.&lt;/author&gt;&lt;author&gt;Optican, L.M.&lt;/author&gt;&lt;/authors&gt;&lt;/contributors&gt;&lt;auth-address&gt;Laboratoryof Sensorimotor Research, National Eye Institute, National Institutes ofHealth, Bldg. 49, Rm. 2A50, 20892, Bethesda, MD,USA&lt;/auth-address&gt;&lt;titles&gt;&lt;title&gt;Effects of tenotomy surgeryon congenital nystagmus waveforms in adult patients. Part II. Dynamical systemsanalysis&lt;/title&gt;&lt;secondary-title&gt;VisionRes&lt;/secondary-title&gt;&lt;/titles&gt;&lt;pages&gt;2357-62&lt;/pages&gt;&lt;volume&gt;43&lt;/volume&gt;&lt;number&gt;22&lt;/number&gt;&lt;keywords&gt;&lt;keyword&gt;CN:TENOT:SURG:&lt;/keyword&gt;&lt;/keywords&gt;&lt;dates&gt;&lt;year&gt;2003&lt;/year&gt;&lt;pub-dates&gt;&lt;date&gt;Oct&lt;/date&gt;&lt;/pub-dates&gt;&lt;/dates&gt;&lt;accession-num&gt;12962992&lt;/accession-num&gt;&lt;label&gt;5.168&lt;/label&gt;&lt;urls&gt;&lt;related-urls&gt;&lt;url&gt;http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Citation&amp;amp;list_uids=12962992&lt;/url&gt;&lt;/related-urls&gt;&lt;/urls&gt;&lt;/record&gt;&lt;/Cite&gt;&lt;/EndNote&gt;<spanstyle='mso-element:field-separator'></span></span><![endif]--><spanstyle='font-size:11.0pt'>(1,2)</span><!--[if supportFields]><spanstyle='font-size:11.0pt'><span style='mso-element:field-end'></span></span><![endif]--><spanstyle='font-size:11.0pt'>. Needless to say, I was shocked to learn that ourunmasked data had continued to be accessed by Optican during our NEI clinicaltrial allowing choices of the data to be analyzed and to prepare these papersto be submitted at about the same time as our first submission (his papers onSeptember 23, 2002 and ours on September 3, 2002). Thus, unknown to me anddespite his initial reprimand, Optican had access to the 880 records unmasked,whose masked analysis took over 550 hours. Optican and Miura should have beenprevented from accessing and using our data. This, and his failure to waituntil publication of our results, was in direct violation of the NEI DSMCguidelines and of their agreements with me. I believe that no one had the rightto give permission to access data in an ongoing study without the knowledge andpermission of all the scientists conducting the study. Furthermore, it is mycontention that no ethical scientist would either seek or accept access toanother’s unmasked data without their knowledge and permission. Unlike theabove evaluation of the scientific merit of the papers, I cannot definitivelyassign specific motive for these extraordinary actions; I do consider them anattack on the integrity of all those who collaborated with me on the carefulINS research we have done for 40 years. I remain confident that the carefulwork of those who actually study INS and tenotomy will survive this unprovokedand baseless attack.<o:p></o:p></span></p><p class=MsoNormal><span style='font-size:11.0pt'><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></span></p><p class=MsoNormal><span style='font-size:11.0pt'><b>Conclusions<o:p></o:p></b></span></p><p class=MsoNormal><span style='font-size:11.0pt'>Bad science (that also wasthe fruit of secretive and deceptive data mining) and questionable motives areall that support this invitation; any underlying agenda remains onlyspeculation. The members of INOS deserve better. These objections, based solelyon the speaker’s qualifications and abnormal behavior suggesting bias, shouldbe sufficient to preclude his speaking on the subject, the final content of thepresentation, notwithstanding. INOS should not reward either poor science orquestionable behavior and certainly not both. Each of us must decide personallywhat, if any, action to take; I cannot support this violation of our trust. Themembers of the audience at INOS 2008 now have access to the informationnecessary to properly evaluate both the presentation (should they choose tolisten to it) and its source. The real victims of this unjustified invitationare the conduct of ethical science and those patients whose physicians withholdeffective treatment under the mistaken impression that there is ascientifically valid controversy about whether tenotomy really improves INS oracquired nystagmus waveforms and, with them, visual function. There is abundantproof already in the literature that it does both.<o:p></o:p></span></p><p class=MsoNormal><span style='font-size:11.0pt'><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></span></p><p class=MsoNormal><span style='font-size:11.0pt'><b>Acknowledgements<o:p></o:p></b></span></p><p class=MsoNormal><span style='font-size:11.0pt'>The author acknowledges thecontributions of the three Reviewers who helped ensure the veracity of thefacts presented herein.<o:p></o:p></span></p><p class=MsoNormal><span style='font-size:11.0pt'><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></span></p><p class=MsoNormal><span style='font-size:11.0pt'><b>References<o:p></o:p></b></span></p><p class=MsoHeader style='margin-left:.5in;text-indent:-.5in'><!--[if supportFields]><spanstyle='font-size:11.0pt'><span style='mso-element:field-begin'></span><spanstyle="mso-spacerun: yes">&nbsp;</span>ADDIN EN.REFLIST <span style='mso-element:field-separator'></span></span><![endif]--><span style='font-size:11.0pt'>1.<spanstyle='mso-tab-count:1'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>MiuraK, Hertle RW, FitzGibbon EJ, Optican LM. Effects of tenotomy surgery oncongenital nystagmus waveforms in adult patients. Part I. Wavelet spectralanalysis<i>.</i></span><span style='font-size:11.0pt'> <i>Vision Res</i></span><spanstyle='font-size:11.0pt'> 2003; 43(22):2345-56.<o:p></o:p></span></p><p class=MsoHeader><span style='font-size:11.0pt'><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></span></p><p class=MsoHeader style='margin-left:.5in;text-indent:-.5in'><spanstyle='font-size:11.0pt'>2.<span style='mso-tab-count:1'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>MiuraK, Hertle RW, FitzGibbon EJ, Optican LM. Effects of tenotomy surgery oncongenital nystagmus waveforms in adult patients. Part II. Dynamical systemsanalysis<i>.</i></span><span style='font-size:11.0pt'> <i>Vision Res</i></span><spanstyle='font-size:11.0pt'> 2003; 43(22):2357-62.<o:p></o:p></span></p><p class=MsoHeader><span style='font-size:11.0pt'><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></span></p><p class=MsoHeader style='margin-left:.5in;text-indent:-.5in'><spanstyle='font-size:11.0pt'>3.<span style='mso-tab-count:1'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>Dell'OssoLF. Tenotomy and congenital nystagmus: a failure to answer the wrong question<i>.</i></span><spanstyle='font-size:11.0pt'> <i>Vision Res</i></span><span style='font-size:11.0pt'>2004; 44:3091-4.<o:p></o:p></span></p><p class=MsoHeader><span style='font-size:11.0pt'><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></span></p><p class=MsoHeader style='margin-left:.5in;text-indent:-.5in'><spanstyle='font-size:11.0pt'>4.<span style='mso-tab-count:1'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>OpticanLM, Miura K, FitzGibbon EJ. Tenotomy and congenital nystagmus: a null result isnot a failure, for &quot;It is not the answer that enlightens, but thequestion&quot;<i>.</i></span><span style='font-size:11.0pt'> <i>Vision Res</i></span><spanstyle='font-size:11.0pt'> 2004; 44:3095-8.<o:p></o:p></span></p><p class=MsoHeader><span style='font-size:11.0pt'><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></span></p><p class=MsoHeader style='margin-left:.5in;text-indent:-.5in'><spanstyle='font-size:11.0pt'>5.<span style='mso-tab-count:1'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>Dell'OssoLF. Responding to more than a response: tenotomy improves INS waveforms. OMLABReport 2007; #071107:1-12. <u><ahref="http://www.omlab.org/Teaching/teaching.html">http://www.omlab.org/Teaching/teaching.html</a></u><o:p></o:p></span></p><p class=MsoHeader><span style='font-size:11.0pt'><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></span></p><p class=MsoHeader style='margin-left:.5in;text-indent:-.5in'><spanstyle='font-size:11.0pt'>6.<span style='mso-tab-count:1'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>SarvananthanN, Proudlock FA, Choudhuri I, Dua H, Gottlob I. Pharmacologic treatment ofcongenital nystagmus<i>.</i></span><span style='font-size:11.0pt'> <i>ArchOphthalmol</i></span><span style='font-size:11.0pt'> 2006; 124(6):916-8.<o:p></o:p></span></p><p class=MsoHeader><span style='font-size:11.0pt'><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></span></p><p class=MsoHeader style='margin-left:.5in;text-indent:-.5in'><spanstyle='font-size:11.0pt'>7.<span style='mso-tab-count:1'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>TomsakRL, Dell'Osso LF, Rucker JC, Leigh RJ, Bienfang DC, Jacobs JB. Treatment ofacquired pendular nystagmus from multiple sclerosis with eye muscle surgeryfollowed by oral memantine<i>.</i></span><span style='font-size:11.0pt'> <i>DJO</i></span><spanstyle='font-size:11.0pt'> 2005; 11(4):1-11.<o:p></o:p></span></p><p class=MsoHeader><span style='font-size:11.0pt'><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></span></p><p class=MsoHeader style='margin-left:.5in;text-indent:-.5in'><spanstyle='font-size:11.0pt'>8.<span style='mso-tab-count:1'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>WangZ, Dell'Osso LF, Jacobs JB, Burnstine RA, Tomsak RL. Effects of tenotomy onpatients with infantile nystagmus syndrome: foveation improvement over abroadened visual field<i>.</i></span><span style='font-size:11.0pt'> <i>JAAPOS</i></span><spanstyle='font-size:11.0pt'> 2006; 10:552-60.<o:p></o:p></span></p><p class=MsoHeader><span style='font-size:11.0pt'><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></span></p><p class=MsoHeader style='margin-left:.5in;text-indent:-.5in'><spanstyle='font-size:11.0pt'>9.<span style='mso-tab-count:1'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>WangZI, Dell'Osso LF, Tomsak RL, Jacobs JB. Combining recessions (nystagmus andstrabismus) with tenotomy improved visual function and decreased oscillopsiaand diplopia in acquired downbeat nystagmus and in horizontal infantilenystagmus syndrome<i>.</i></span><span style='font-size:11.0pt'> <i>JAAPOS</i></span><spanstyle='font-size:11.0pt'> 2007; 11:135-41.<o:p></o:p></span></p><p class=MsoHeader><span style='font-size:11.0pt'><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></span></p><p class=MsoHeader style='margin-left:.5in;text-indent:-.5in'><spanstyle='font-size:11.0pt'>10.<span style='mso-tab-count:1'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>WangZ, Dell'Osso LF, Zhang Z, Leigh RJ, Jacobs JB. Tenotomy does not affectsaccadic velocities: Support for the &quot;small-signal&quot; gain hypothesis<i>.</i></span><spanstyle='font-size:11.0pt'> <i>Vision Res</i></span><span style='font-size:11.0pt'>2006; 46:2259-67.<o:p></o:p></span></p><p class=MsoHeader><span style='font-size:11.0pt'><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></span></p><p class=MsoHeader style='margin-left:.5in;text-indent:-.5in'><spanstyle='font-size:11.0pt'>11.<span style='mso-tab-count:1'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>HertleRW, Dell'Osso LF, FitzGibbon EJ, Thompson D, Yang D, Mellow SD. Horizontalrectus tenotomy in patients with congenital nystagmus. Results in 10 adults<i>.</i></span><spanstyle='font-size:11.0pt'> <i>Ophthalmology</i></span><span style='font-size:11.0pt'> 2003; 110:2097-105.<o:p></o:p></span></p><p class=MsoHeader><span style='font-size:11.0pt'><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></span></p><p class=MsoHeader><span style='font-size:11.0pt'><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></span></p><p class=MsoHeader style='margin-left:.5in;text-indent:-.5in'><!--[if supportFields]><spanstyle='font-size:11.0pt'><span style='mso-element:field-end'></span></span><![endif]--><spanstyle='font-size:11.0pt'><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></span></p><h2><span style='font-size:11.0pt'><b>Citation<o:p></o:p></b></span></h2><p class=MsoNormal><span style='font-size:11.0pt'>Although the informationcontained in this paper and its downloading are free, please acknowledge itssource by citing the paper as follows:<o:p></o:p></span></p><p class=MsoNormal><span style='font-size:11.0pt'><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></span></p><p class=MsoNormal><span style='font-size:11.0pt;color:black'>Dell’Osso, L.F.:INOS 2008: Ethical Science or Something Else? OMLAB Editorial #071107, 1</span><spanstyle='font-size:11.0pt'>-8<span style='color:black'>, 2007. </span><ahref="http://www.omlab.org/Editorial/editorial.html">http://www.omlab.org/Editorial/editorial.html</a><o:p></o:p></span></p><p class=MsoNormal><span style='font-size:11.0pt'><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></span></p><p class=MsoNormal><span style='font-size:11.0pt'><b>Note: </b></span><spanstyle='font-size:11.0pt'><i>This editorial was originally numbered as #070707(date written) and was corrected to #071107 (date posted) on February 7, 2008.<o:p></o:p></i></span></p><p class=MsoNormal><span style='font-size:11.0pt'><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></span></p><p class=MsoNormal><span style='font-size:11.0pt'><b><i>Comment (added 7/23/07)</i></b></span><spanstyle='font-size:11.0pt'><o:p></o:p></span></p><p class=MsoNormal><span style='font-size:11.0pt'>On July 16, 2007, a link tothis Editorial was posted on the NANOSNET list (prompted by the posting of theINOS 2008 link on the same list). As a result of that posting, the factscontained in this Editorial are now known to over 300 (and counting) potentialattendees at INOS 2008. My obligation to provide full disclosure to the membersof NANOS was accomplished in two days (relying on Google alone may not haveaccomplished that much in a year). Despite the fact that most of theinformation in this Editorial is a matter of public record, the organizers ofINOS 2008 would not disclose it. Fortunately, what was to be disguised as anobjective scientific presentation from an &quot;expert&quot; will have neither&quot;controversy&quot; nor &quot;drama&quot; (does INOS 2008 really need ahawker?). I do not plan to dignify Optican's presentation with my presence. IfOptican's two papers or his Response are any indication, the person responsiblefor that ill-advised invitation will have to be satisfied with misinformationand possibly worse; that is what his decision will bring to those INOSattendees who choose to attend that talk. My advice is, visit a winery or havea big breakfast instead.<o:p></o:p></span></p><p class=MsoNormal><span style='font-size:11.0pt'><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></span></p><p class=MsoNormal><span style='font-size:11.0pt'>To my surprise as well asthat of others, my simple posting of links to an Editorial and a Report onanother site was construed as a &quot;personal attack&quot; by the NANOSNETlist maven, Preston Calvert, who proceeded to remove my ability to post furtherinformation on the list. In contrast, my posting has appeared on other similarprofessional lists with no negative reaction by the responsible list managers.Apparently, Calvert wishes to censor any controversy, not only on NANOSNET butalso on other sites on the web. My Editorial and Report only present therelevant facts and several of my opinions (clearly identified as such) andcontain no personal attacks. Despite this, he continues to mischaracterize bothand refused to reverse his decision (a decision that may be supported by otherson the NANOSNET committee).<o:p></o:p></span></p><p class=MsoNormal><span style='font-size:11.0pt'><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></span></p><p class=MsoNormal><span style='font-size:11.0pt'>My monitoring the NANOSNETlist was for educational (i.e., NANOS members') purposes only; that too, washalted, since I no longer receive it. However, as a Fellow of NANOS, I shallcontinue to monitor the list using other means and respond directly to NANOSNETmembers who need accurate information on those subjects where I can provide it,especially when a posting is in error. I regard this as my obligation to themembership. Calvert also refused to post my side of this matter, claiming thatto do so would somehow &quot;reiterate&quot; my attack. It might also haverevealed the weakness of his position. He may disagree with my opinionregarding to Optican's lack of credibility on this subject (unlike Optican'sResponse, my Editorial does not contain comments on his other work) but Calvertis clearly overreaching in trying to apply his rules to another site and iswrong to claim &quot;personal attack&quot; where none exists. <o:p></o:p></span></p><p class=MsoNormal><span style='font-size:11.0pt'><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></span></p><p class=MsoNormal><span style='font-size:11.0pt'>Censorship hasn't worked inthe past and is no longer viable. We all appreciate the effort put in by thosewho monitor web sites or organize meetings. However, we do not expect them toabuse their positions or act with personal agendas to the detriment of theirorganizations or membership. We certainly do not surrender our rights to holdor express our data-based opinions, the essence of scientific discourse.<o:p></o:p></span></p><p class=MsoNormal><span style='font-size:11.0pt'><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></span></p><p class=MsoNormal><span style='font-size:11.0pt'>LF Dell'Osso, PhD 7/23/07<o:p></o:p></span></p><p class=MsoNormal><span style='font-size:11.0pt'><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></span></p><p class=MsoNormal><span style='font-size:11.0pt'><b><i>Comment (added on8/31/07)<o:p></o:p></i></b></span></p><p class=MsoNormal><span style='font-size:11.0pt'>Recently, Dr. Lance Opticanposted a letter to INOS members in which he denied the veracity of thehistorical record detailed in OMLAB Editorial #071107 and in OMLAB Report#071107. In response to his blanket denials, I can only reiterate that theabove-mentioned record is both accurate and well documented, as attested to byDr. Rich Hertle. The OMLAB documents stand as the only description exposing theextraordinary measures taken by Dr. Optican to prematurely access data from anongoing masked-data, clinical trial to which he was not a participating party (<i><u>whichhe did not deny</u></i></span><span style='font-size:11.0pt'>) and to use thatdata, unmasked, (<i><u>which he did not deny</u></i></span><spanstyle='font-size:11.0pt'>) to undermine the trial. In my opinion, his own&quot;inappropriately aggressive&quot; and unethical actions violated the DSMCrules under which the trial was conducted and the assurances made to me by theNEI in return for my participation. Those assurance were in accordance with NIHPolicy [NIH Data Sharing Policy], that states no one outside the study wouldhave access to or use data until publication of the results by theinvestigators conducting the trial (i.e., guaranteeing the right of &quot;firstuse&quot; to those conducting a study). <i><u>He did not deny</u></i></span><spanstyle='font-size:11.0pt'> accessing our data and publishing his papers beforeour results were in press, as required by the above policy.<o:p></o:p></span></p><p class=MsoNormal><span style='font-size:11.0pt'><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></span></p><p class=MsoNormal><span style='font-size:11.0pt'>In his letter, Dr. Opticancontinued to rely on the cunning sentence structure exhibited in hisunprofessional Response to my Letter to the Editor of VR; neither that nor&quot;neutrality&quot; is an acceptable substitute for truthfulness. Hisdenials are aimed at whether or not his actions (<i><u>which he did not deny</u></i></span><spanstyle='font-size:11.0pt'>), as documented in the Editorial and Report, actuallyviolated existing regulations. That is not for him to determine but forobjective committees that exist expressly for that purpose.<spanstyle="mso-spacerun: yes">&nbsp; </span>Because of Dr. Optican, the literaturenow contains two extraordinarily flawed papers on INS and a personal attack onthe integrity of the pioneering INS research performed in our Laboratory, theLaboratory of Dr. Robert Williams, and on all of the scientists who conductedthat research. He squandered his opportunity for a &quot;productive scientificdiscourse&quot; when he failed to respond to the scientific criticismscontained in my Letter and instead, attacked my integrity and that of my work.I urge any who wish to read his disrespectful Response to have an open copy ofOMLAB REPORT #071107 which provides a paragraph-by-paragraph exposure of themany statements based on false premises or made without citing the relevantconflicting information.<o:p></o:p></span></p><p class=MsoNormal><span style='font-size:11.0pt'><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></span></p><p class=MsoNormal><span style='font-size:11.0pt'>If Dr. Optican wishes toidentify specific statements in either the Editorial or Report that are&quot;factually in error&quot; (<i><u>his letter failed to identify any</u></i></span><spanstyle='font-size:11.0pt'>), he is welcome to submit them to me along with anydocumentation he might have. I will then append them and my response to theappropriate posted document. The OMLAB Editorial and Report are the onlyretrievable documentation of both his extraordinary behavior and the fallaciescontained in his papers; they will remain so to prevent the misperception thatOptican's two papers were the product of an unbiased and properly conducted studyinto the effects of tenotomy; the latter was accomplished by the NEI-sponsoredClinical Trial conducted and reported on by Hertle et al. The flawed attemptsby Optican's two papers to deny the demonstrated positive effects on nystagmuswaveforms cannot be compared to the results of our carefully designed andstrictly supervised, masked-data analysis of INS waveforms. During the past fewyears, I have been appalled by members of both the research and clinicalcommunities who cite this supposedly negative evidence of tenotomy'seffectiveness yet could not tell a wavelet from a ringlet. Those that citethese papers after merely reading their overreaching abstracts do a disserviceto the careful research that has established tenotomy as both viable and beneficialfor nystagmus and, more importantly, to the patients who may benefit from thisrevolutionary therapy. One needs only to read the many publications thatfollowed those in question to realize that new experiments documenting theprogress of the tenotomy procedure in both INS and acquired nystagmus havealready been conducted and reported.<o:p></o:p></span></p><p class=MsoNormal><span style='font-size:11.0pt'><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></span></p><p class=MsoNormal><span style='font-size:11.0pt'>Dr. Optican states that heknows of no reason to accuse Dr. Carl Kupfer of attempting to hijack my work.Dr. Optican was not a party to our Clinical Trial and would not have had reasonto be at the meeting where this took place. Dr. Hertle was and reported itdirectly to me at the time it occurred; as a senior member of the researchteam, I did have a right to know. Several years earlier, when discussing mywork with Dr. Williams on the achiasmatic Belgian sheep dogs, Dr. Kupferstated, &quot;Nothing clinically useful will come from studying the eyemovements of dogs;&quot; I believe history has proved him wrong.<o:p></o:p></span></p><p class=MsoNormal><span style='font-size:11.0pt'><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></span></p><p class=MsoNormal><span style='font-size:11.0pt'>Whether Dr. Optican's actionsviolated any data- or patient-protection agreement or NEI Data and SafetyMonitoring Committee (DSMC) guidelines (or severely bent them), is somethingfor others to determine. However, if the NEI's rules protecting a researcher'sor patients' data were not violated by Dr. Optican's accessing and using themwithout obtaining my permission, especially after I specifically forbadefurther access, a chilling message will have been sent to all researchersconsidering collaboration with NEI employees. Such a result of Optican'sactions would be a disservice to the many ethical scientists at the NEI. <i><u>Despitehis protestations to the contrary</u></i></span><span style='font-size:11.0pt'>in his letter to INOS members, Dr. Optican was reprimanded by Dr. Hertle at myinsistence and was told to cease and desist or the matter would be broughtbefore the DSMC; he elected to forgo that experience but only pretended tocomply. <i><u>He was told specifically not to submit his Neuroscience abstractand he did not submit it.</u></i></span><span style='font-size:11.0pt'> Had heignored that directive, his actions would have immediately prompted a formalcharge of misconduct.<o:p></o:p></span></p><p class=MsoNormal><span style='font-size:11.0pt'><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></span></p><p class=MsoNormal><span style='font-size:11.0pt'>As pointed out in theEditorial, Dr. Optican's own CV demonstrates his dearth of experience instudying either INS or the effects of tenotomy. He should never have acceptedthis ill-advised invitation to speak at INOS 2008 on a topic for which he has ademonstrable lack of experience, expertise, and objectivity. There are at leasta dozen well-qualified scientists who could make a more well-informedpresentation and who will not carry the baggage Dr. Optican has inflicted onhimself.<o:p></o:p></span></p><p class=MsoNormal><span style='font-size:11.0pt'><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></span></p><p class=MsoNormal><span style='font-size:11.0pt'>As an Italian-American, I wastaught at an early age that respect was not a verb to bandy about but somethingyou demonstrate by your actions. For someone who, over the past six years, hasshown both disrespect and disdain not only for my and my colleagues’ reputationsfor integrity, but also for ethical scientific behavior, data- andpatient-protection and the NEI institutional policy governing them, and fulldisclosure to Journal reviewers (and ultimately to the readers of the publishedmaterial), his “respectfully” submitted self-serving request is pure chutzpah.If Optican truly wishes to demonstrate his respect for ethical science, theINOS membership, and for the INS research he has so unprofessionally maligned,he should decline the invitation. As a Fellow of NANOS and an INOS member, Iurge him to do so.<o:p></o:p></span></p><p class=MsoNormal><span style='font-size:11.0pt'><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></span></p><p class=MsoNormal><span style='font-size:11.0pt'>LF Dell'Osso, PhD 8/31/07<o:p></o:p></span></p><p class=MsoNormal><span style='font-size:11.0pt'><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></span></p><p class=MsoNormal><span style='font-size:11.0pt'><b><i>Epilog (added on8/6/08)<o:p></o:p></i></b></span></p><p class=MsoNormal><span style='font-size:11.0pt'>To express my opposition tothe heedless action of the INOS “committee” responsible for an indefensibleinvitation to a speaker with no expertise in the either INS recording,calibration, analysis, or therapy, I chose to spend the month of June inSardinia (attending a wedding and lecturing on eye-movements) and southernItaly (visiting friends and relatives while continuing my genealogical researchin Calabria, Basilicata, and Puglia).<o:p></o:p></span></p><p class=MsoNormal><span style='font-size:11.0pt'><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></span></p><p class=MsoNormal><span style='font-size:11.0pt'>Several objective scientistswho did attend the talk in question (instead of sampling the wines of the NapaValley, as I recommended) reported their impressions to me. They expressedtheir disappointment at both the “unimpressive” and “unbalanced” content ofOptican’s talk, the lack of alternatives to proven analysis methods, at leastone false statement about tenotomy, and his inability to satisfactorily addressthe concerns and questions raised after the talk.<o:p></o:p></span></p><p class=MsoNormal><span style='font-size:11.0pt'><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></span></p><p class=MsoNormal><span style='font-size:11.0pt'>Hopefully, I can now closethis ugly chapter chronicling what the evidence suggests were politicallydriven actions of some in our community of scientists with the satisfactionthat comes from the knowledge that I did what was necessary to educate the INOSmembership both to the insult to them embodied in the Optican invitation andthe unethical behavior that caused this problem in the first place. <o:p></o:p></span></p><p class=MsoNormal><span style='font-size:11.0pt'><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></span></p><p class=MsoNormal><span style='font-size:11.0pt'>The professional skeptics andtheir minions have failed miserably to either: 1) demonstrate scientificallythat the tenotomy procedure does not benefit nystagmus patients or 2) provide aviable alternative mechanism to the proprioceptive-control hypothesis. Perhapsnow objective and unbiased evaluation can continue of the data that has thusfar demonstrated the multiple beneficial clinical effects of the tenotomyprocedure and supported the proprioceptive-control hypothesis. I remainconfident that both the resulting paradigm shift in nystagmus surgery and therenewed appreciation of the role of proprioception in eye-movement control willemerge as driving forces in future contributions to both basic and clinicalocular motor research. That is, and must be, the reward for scientific study,as the search for “ultimate truth” is an endless one.<o:p></o:p></span></p><p class=MsoNormal><span style='font-size:11.0pt'><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></span></p><p class=MsoNormal><span style='font-size:11.0pt'>LF Dell'Osso, PhD 8/6/08<o:p></o:p></span></p></div></body></html>